tiprankstipranks
Trending News
More News >

Synairgen to Re-register as Private Company and Delist from AIM

Story Highlights
Synairgen to Re-register as Private Company and Delist from AIM

Don’t Miss TipRanks’ Half-Year Sale

Synairgen ( (GB:SNG) ) has shared an announcement.

Synairgen plc announced the successful passing of resolutions at its General Meeting, leading to its re-registration as a private limited company and delisting from AIM. This strategic move involves appointing Asset Match to facilitate trading of its shares through an electronic off-market dealing facility, ensuring continued liquidity for shareholders. The transition reflects Synairgen’s ongoing efforts to streamline operations and adapt to market conditions, potentially impacting its industry positioning and stakeholder engagement.

More about Synairgen

Synairgen is a UK-based respiratory company focused on developing SNG001, an inhaled formulation of interferon beta, as a potential broad-spectrum antiviral treatment for severe viral lung infections. The company aims to address the global need for effective antiviral therapies, as millions are hospitalized annually due to viral lung infections, with no approved treatments currently available for most patients.

YTD Price Performance: -61.19%

Average Trading Volume: 1,416,042

Technical Sentiment Signal: Buy

Current Market Cap: £11.56M

For an in-depth examination of SNG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1